Membranous obstruction of the inferior vena cava and extensive bone marrow necrosis associated with catastrophic antiphospholipid syndrome

Journal of Clinical Rheumatology

Volumn 5, Issue 5, 1999, Pages 279-284

  Spyropoulos, Alex C ^a  

^a Lovelace Sandia Health Systems   (United States)

Author keywords

Anticardiolipin antibodies; Bone marrow necrosis; Budd Chiari syndrome; Catastrophic antiphospholipid syndrome; Membranous obstruction of the inferior vena cava

Indexed keywords

ANTICOAGULANT AGENT; CARDIOLIPIN ANTIBODY; D DIMER; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; HEPARIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; PHOSPHOLIPID ANTIBODY;

ADULT; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BONE MARROW BIOPSY; BONE MARROW NECROSIS; BUDD CHIARI SYNDROME; CASE REPORT; CAVOGRAPHY; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; INFERIOR CAVA VEIN OBSTRUCTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL;

EID: 0032827875     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-199910000-00008     Document Type: Article

References (24)

1. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992;19:508-12.
2. Mazzuchelli R, Barbadillo C, Youssef H, Bernaldo de Quiros LB, Mulero J, Andreu-Sanchez JL. Catastrophic antiphospholipid syndrome (CAS): a rare manifestation of the antiphospholipid antibody syndrome. Clin Exp Rheumatol 1993;11:653-7.
3. Ruffatti A, De Silvestro G, Ghrardello A, Calligra A, Del Ross T, Thiene G, et al. A catastrophic antiphospholipid syndrome: the importance of high levels of warfarin anticoagulation. J Intern Med 1994;235:81-3.
4. Kennedy M, Jackson J, Khan I, Keeling PW, Gaffney E. Catastrophic antiphospholipid syndrome in the absence of IgG anticardiolipin antibodies. Scand J Rheumatol 1995;24:389-91.
5. Levy RA. Clinical manifestations of the aPL syndrome. Lupus 1996;5:393-7.
6. Asherson RA. The catastrophic antiphospholipid syndrome, 1998: a review of the clinical features, possible pathogenesis and treatment. Lupus 1998;7:S55-62.
7. Asherson RA, Cervera R, Piette JC, Font J, Lie JT, Borcoglu A, et al. Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998,77:195-207.
8. Asherson RA, Piette J-C. The catastrophic antiphospholipid syndrome 1996: acute multi-organ failure associated with antiphospholipid antibodies - a review of 31 patients. Lupus 1996;5:414-7.
9. Piette JC. The catastrophic antiphospholipid syndrome: report of two cases. Presse Med 1997;22;26:421.
10. Neuwelt CM, Daikh DI, Linfoot JA, Pfister DA, Young RG, Webb RL, et al. Catastrophic antiphospholipid syndrome: response to repeated plasmapheresis over three years. Arthritis Rheum 1997;40:1534-9.
11. Boerma C, Derksen R, Van der Wiel B. An acute multiorgan thrombotic disorder associated with antiphospholipid antibodies: two 'catastrophic' cases. Ann Rheum Dis 1997;56: 568-9.
12. Chinnery PF, Shaw PJ, Ince PG, Jackson GH, Bishop RI. Fulminant encephalopathy due to the catastrophic primary antiphospholipid syndrome. J Neurol Neurosurg Psychiatry 1997;62:300-1.
13. Mackworth-Young CG, Melia WM, Harris EN, Gharavi AE. The Budd-Chiari syndrome: possible pathogenetic role of antiphospholipid antibodies. J Hepatol 1986;3:83-6.
14. Pelletier S, Landi B, Piette JC, Ekert P, Coutellier A, Desmoulins C, et al. Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome. J Hepatol 1994; 21:76-80.
15. Archimandritis A, Christopoulou V, Tsirantonaki M, Vlachoyiannopoulos P, Zavos G, Aroni K. Budd-Chiari syndrome in the context of antiphospholipid syndrome: diagnostic and therapeutic implications. Lupus 1995;4:329-31.
16. Garrido JA, Diaz Peromingo JA, Martinez-Deben FS, Grandes J. Budd-Chiari syndrome as the presenting form of primary antiphospholipid syndrome. An Med Interna 1996;13: 355-6.
17. Yun YY, Yoh KA, Yang HI, Park SH, Lee SH, Cho CS, et al. A case of Budd-Chiari syndrome with high antiphospholipid antibody in a patient with systemic lupus erythematosus. Korean J Intern Med 1996;11:82-6.
18. Bulvik S, Aronson I, Ress S, Jacobs P. Extensive bone marrow necrosis associated with antiphospholipid antibodies. Am J Med 1995;98: 572-4.
19. Moore J, Ma DD, Concannon A. Non-malignant bone marrow necrosis: a report of two cases. Pathology 1998;30:318-20.
20. Paydas S, Kocak R, Zorludemir S, Baslamisli F. Bone marrow necrosis in antiphospholipid syndrome. J Clin Pathol 1997;50:261-2.
21. Egan RM, Munn RK. Catastrophic antiphospholipid syndrome presenting with multiple thromboses and sites of avascular necrosis. J Rheumatol 1994;21:2376-9.
22. Riemens SC, Haagsma EB, Kok T, Gouw ASH, van der Jagt EJ. Familial occurrence of membranous obstruction of the inferior vena cava: arguments in favor of a congenital etiology. J Hepatol 1995;22:404-9.
23. Terabayashi H, Okuda K, Nomura F, Ohnishi K, Wong P. Transformation of inferior vena caval thrombosis to membranous obstruction in a patient with the lupus anticoagulant. Gastroenterology 1986;91:219-24.
24. Pierangeli SS, Liu XW, Barker JH, Anderson G, Harris EN. Induction of thrombosis in a mouse model by IgG, IgM, and IgA immunoglobulins from patients with the antiphospho-lipid syndrome. Thromb Haemost 1995; 74:1361-7.